Dirlotapide (CP742033) is a gut-selective inhibitor ofmicrosomal triglyceride transfer protein (MTP)that reliably produces weight loss in obese dogs.

Dogs receiving 0.3 mg dirlotapide/kg once daily have a small but significant (P=0.018) decrease (6.16 ± 2.22%, mean ± SD) in crude fat digestibility compared with the placebo-treated food-restricted dogs, but no difference in crude protein, dry matter, or energy digestibility is observed. Dirlotapide effectively reduces appetite and energy intake without affecting nutrient digestibility, except for a minimal decrease in fat digestibility^[1]. Dirlotapide (0.5 mg/kg) results in a high rate of weight loss (3.3% weekly) and anorexia, emesis, and loose stools for some dogs. Dirlotapide produces weight loss by both reducing appetite (about 90% of the weight loss activity) and by increasing fecal fat excretion (about 10% of the weight loss activity)^[2].

674.71

Solid

C₄₀H₃₃F₃N₄O₃

481658-94-0

地洛他派

Room temperature in continental US; may vary elsewhere.